BOUNDLESS BIO, INC.

Andere talen Boundless Bio, Inc.

Aandelen

BOLD

US10170A1007

Geschatte realtime Cboe BZX Andere beurzen 17:02:47 28-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
10,38 ^USD	-8,22%		-3,09%	0,00%

23/04	BOUNDLESS BIO, INC. : Guggenheim handhaaft koopadvies	ZM
23/04	BOUNDLESS BIO, INC. : Piper Sandler bevestigt koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights	13/05
Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024	06/05
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications	11/04
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications	11/04
Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA -Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024	09/04
Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024	08/04
Boundless Bio Insider Bought Shares Worth $3,200,000, According to a Recent SEC Filing	04/04
Boundless Bio Insider Bought Shares Worth $3,200,000, According to a Recent SEC Filing	04/04
Boundless Bio, Inc.(NasdaqGS:BOLD) added to NASDAQ Composite Index	01/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.

PROFITEER NU